Home › Neuroblastoma › Connecticut › Hartford
Neuroblastoma klinische studies in Hartford, CT
8 studies voor Neuroblastoma zoeken deelnemers op locaties in en rond Hartford (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruterenFase 3
- Connecticut Children's Medical Center, Hartford
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekruterenFase 2
- Connecticut Children's Hospital, Hartford
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruterenFase 1/2
- Connecticut Children's Hospital, Hartford
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruterenFase 1/2
- Connecticut Children's Hospital, Hartford
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekruterenFase 2
- Connecticut Children's Hospital, Hartford
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruterenFase 3
- Connecticut Children's Medical Center, Hartford
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruterenFase 2
- Connecticut Children's Hospital, Hartford
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Rekruteren
- Connecticut Children's Medical Center, Hartford
Neuroblastoma studies in andere steden
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Dallas, TX9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- St. Louis, MO9 studies
- Aurora, CO8 studies
- Minneapolis, MN8 studies
- Birmingham, AL8 studies
- Atlanta, GA7 studies
- San Francisco, CA7 studies
Andere studies in Hartford
- Niet-kleincellige longkanker12 studies
- Longkanker11 studies
- Ernstige depressieve stoornis9 studies
- Kanker (alle vormen)9 studies
- Borstkanker9 studies
- Multipel myeloom7 studies
- Aldermeesklierkanker7 studies
- Prostaatkanker7 studies
- Eierstokkanker7 studies
- Cardiovasculaire ziekte7 studies
- Hartfalen7 studies
- Sikkelcelziekte5 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.